What to do: Do not use the affected product. Return it to your local pharmacy for proper disposal. Seek medical attention if you or your child have used this product and are experiencing persistent or worsening symptoms, such as fevers, or facial pain or pressure. Consult a healthcare professional if you or your child have used this product and have health concerns.
Affected products
Product
DIN
Lot
Expiry
APO-Mometasone nasal spray, 50 mcg/metered spray
02403587
TX5343
TZ2586
Sep 2025
Oct 2025
Issue
Apotex Inc. is recalling two lots of APO-Mometasone nasal spray due to possible bacterial contamination with Burkholderia cepacia complex (Bcc). Bcc is a group of bacteria that poses a low medical risk to most healthy people; however, children, those with chronic lung diseases, people who are pregnant, seniors and those with a weakened immune system may be at a higher risk of illness.
APO-Mometasone nasal spray is a prescription drug used to treat seasonal and year-round nasal allergy symptoms (such as itchy, stuffy or runny nose and sneezing) in children 3-11 years old. It is also used to treat sinusitis (sinus inflammation) in adults and children 12 years of age and older, and nasal polyps in adults.
The effects of Bcc vary widely, ranging from no symptoms at all to serious infections. In severe cases, Bcc can lead to bloodstream infections that may result in sepsis (a serious medical condition caused by an overwhelming immune response to an infection) and death. Bcc is often resistant to common antibiotics. People experiencing persistent or worsening symptoms, such as fevers, or facial pain or pressure, should seek medical attention.
Health Canada is monitoring the company's recall and its implementation of corrective and preventative actions. Supply might be temporarily constrained as a result of this recall. You should speak to your healthcare provider about what suitable alternative treatments are available to you or your child.
What you should do
Do not use the affected product. Return it to your local pharmacy for proper disposal.
Seek medical attention if you or your child have used this product and are experiencing persistent or worsening symptoms, such as fevers, or facial pain or pressure. Consult a health care professional if you or your child have used this product and have health concerns.
Contact Apotex Inc. via Sedgwick by calling 1-844-265-7389 if you have questions about this recall.
Generating cutting-edge therapeutics requires precision, safety, and efficiency from manufacturing equipment. The next generation of oligo manufacturing, the process of producing short sequences of nucleotides (building blocks of DNA or RNA),...
Today, BUBS Naturals, an innovator in health and wellness, reaffirms its commitment to supporting veterans' transition back to civilian life through every purchase of all-natural supplements. In honor of May's National Military Appreciation Month,...
The Beryl Institute announces the publication of Volume 11, Issue 1 of Patient Experience Journal (PXJ), an international, open access, peer-reviewed journal focused on research and proven practices related to understanding and improving the patient...
On Friday, May 3rd, 2024, Union of Medical Care and Relief Organizations-Canada (UOSSM Canada) and Canadians for Palestine will be delivering a press conference regarding Canadian doctors canceling their Canadian Medical Association (CMA) membership...
Prominently featured in The Inner Circle, Katherine A. Daly, MD, is acknowledged as a Distinguished Medical Professional for her work in the Pediatrics and Psychiatry Fields.
Dr. Daly began her academic journey at the University of...